On September 27, 2023, MediciNova, Inc. (NASDAQ:MNOV) announced results from the nonclinical studies conducted under its contract with the Biomedical Advanced Research and Development Authority (BARDA ...
MediciNova Inc (NASDAQ: MNOV) will conduct a mouse study to investigate the efficacy of MN-166 (ibudilast) in a murine model of chlorine-induced lung injury and lethality. After mice are exposed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback